D-0348-2026 Class II Ongoing

Recalled by Wizcure Pharmaa Private Limited — Bhiwadi, N/A

FDA drug recall D-0348-2026 was initiated by Wizcure Pharmaa Private Limited on Dec 31, 2025 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices. The recall status is ongoing. Affected quantity: 11,520 cartons.

Recall details

Product Type
Drugs
Report Date
Mar 4, 2026
Initiation Date
Dec 31, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
11,520 cartons

Product description

Vista Meibo Tears Propylene Glycol 0.6% w/v Eye Drops Advanced Dry Eye Relief Revitalizing Formula, 10 ml (1/3 fl.oz.), Wizcure Pharmaa PVT. LTD., H-881, Phase 3, RIICO Industrial Area, Bhiwadi-301019, India, Manufactured for and distributed by: hi-health, 15207 N. 75th Street, Suite #104, Scottsdale, AZ 85260, NDC 77790-003-10.

Reason for recall

Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.

Distribution pattern

Distributed Nationwide in the USA

Code information

All lots

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0348-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0348-2026. Report a data issue: hello@regdatalab.com.